Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 19Myelodysplastic Syndromes 17Hodgkin Disease 17Lymphoma, Non-Hodgkin 15Myeloproliferative Disorders 13Multiple Myeloma 13Lymphoma, Mantle-Cell 13Leukemia, Myelomonocytic, Chronic 13Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Prolymphocytic 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Prolymphocytic, T-Cell 4

Interventions

Nivolumab 13Ipilimumab 10pembrolizumab 8cemiplimab 6Surveys and Questionnaires 6Biopsy 6aldesleukin 5Radiotherapy 5Interleukin-2 5Blood Specimen Collection 5Temozolomide 4Sirolimus 4Photochemotherapy 4Mohs Surgery 4HhAntag691 4Fluorouracil 4Educational Status 4Cyclophosphamide 4sonidegib 3fludarabine phosphate 3fludarabine 3avelumab 3Vemurafenib 3Surgical Procedures, Operative 3Radiation 3Petrolatum 3Cetuximab 3Aminolevulinic Acid 3trametinib 2dabrafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Skin Neoplasms × Cyclosporins × Clear all
NCT00133887 2025-12-26

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Hospices Civils de Lyon

Phase 3 Completed
77 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡